logo
Select company
Select metric
1.07Price to Sales
VS
Market
70
Sector
80
Industry
94
History
93
$ 0.15Close
$ 0.15 - $ 1.11 52-Week Range
Ticker Information

Ticker

CARM

Company Name

CARISMA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CARISMA THERAPEUTICS INC - Price to Sales Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CARM - P/S Historical data
DateMarket CapitalizationPrice to SalesRevenues
6/30/2025$ 11.49M1.07$ 10.77M
3/31/2025$ 7.77M0.39$ 19.96M
12/31/2024$ 12.95M0.66$ 19.63M
9/30/2024$ 43M2.12$ 20.27M
6/30/2024$ 37.43M1.81$ 20.71M
3/31/2024$ 62.73M4.16$ 15.07M
12/31/2023$ 86.82M5.82$ 14.92M
9/30/2023$ 106.74M10.04$ 10.63M
6/30/2023$ 238.89M5.1$ 46.8M
3/31/2023$ 227.44M5.26$ 43.24M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CARISMA THERAPEUTICS INC's latest trailing twelve months (TTM) P/S stands at 12.78.
  • Over the past 5 years, CARISMA THERAPEUTICS INC's average P/S has been 11.
  • The median P/S for CARISMA THERAPEUTICS INC during this period was 4.94
  • CARISMA THERAPEUTICS INC reached its highest P/S over the past 5 years at 43.21.
  • The lowest P/S recorded by CARISMA THERAPEUTICS INC in the same timeframe 0.39

CARISMA THERAPEUTICS INC's P/S vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

P/S Benchmarks
CompanyP/S
CSCIF : COSCIENS BIOPHARMA INC 1.18BOLT : BOLT BIOTHERAPEUTICS INC 2.51JAGX : JAGUAR HEALTH INC 0.38VSEE : VSEE HEALTH INC 1.21TRAW : TRAWS PHARMA INC 3.94CRIS : CURIS INC 1.83MRKR : MARKER THERAPEUTICS INC 3LGVN : LONGEVERON INC 6.3CYCN : CYCLERION THERAPEUTICS INC 4.44LYRA : LYRA THERAPEUTICS INC 14.42

Definition of Price to Sales

[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
Market Cap / Revenues
(=) P/S
P/S for CARISMA THERAPEUTICS INC is calculated as follows: Market Cap [ $ 143.57M ] / Revenues [ $ 11.24M ]
(=) P/S [ 12.78 ]

CARM - Price to Sales, Last 5 years

0.39

Minimum

Mar 31, 2025

43.21

Maximum

Jun 30, 2021

11

Average

4.94

Median

P/S Benchmark Analysis

The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
filtered constituents3.41K
min0
max11.15
average2.62
median1.97
std2.38